Emord & Associates is dedicated to serving the needs of its national client base. The firm’s attorneys represent clients in constitutional and administrative law cases before the Food and Drug Administration (FDA), the Federal Trade Commission (FTC), the Drug Enforcement Administration (DEA), the Department of Justice (DOJ), the Department of the Interior, the Bureau of Land Management (BLM), the National Park Service (NPS), the Equal Employment Opportunity Commission, the Environmental Protection Agency (EPA), and the Federal Communications Commission (FCC).
COMMENTERS OPPOSE GLAXOSMITHKLINE PETITION SEEKING TO BAN DIETARY SUPPLEMENT WEIGHT LOSS CLAIMS
ROCKVILLE, M.D. - On behalf of Durk Pearson, Sandy Shaw, and Life Enhancement Products, Inc., Emord & Associates, P.C. filed on October 31, 2008 a comment with FDA opposing the GlaxoSmithKline Citizen Petition for FDA to treat weight loss claims for dietary supplements as disease claims.
GlaxoSmithKline's petition would have FDA categorically ban claims that supplements can assist in weight loss or dieting, producing an anti-competitive effect, favoring GlaxoSmithKline's over-the-counter weight loss drug Alli. The commenters challenged the legality of that proposed action under the First Amendment and the Administrative Procedure Act, and noted GlaxoSmithKline's conflict of interest. The comment included over fifty-five articles from peer-reviewed publications in support of weight loss effects of specific dietary ingredients found in weight loss dietary supplements.